Concepedia

Karl J. Erlandson

KJ

Statistics

Publications

18

Citations

1.1K

H-Index

16

Active since

2004

Affiliations

Biomedical Advanced Research and Development Authority(Current)

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Office of Readiness and Response

Center for Biologics Evaluation and Research

Karl J. Erlandson is an author at Biomedical Advanced Research and Development Authority specializing in infectious diseases, molecular virology, and life sciences.

Publications per year

2004–2023

18

Publications

18

Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates

Kristen E. Pascal, Drew Dudgeon, John C. Trefry et al. · The Journal of Infectious Diseases · 2018 · 186 citations · Full text

, , +17

A role for the two-helix finger of the SecA ATPase in protein translocation

Karl J. Erlandson, Stephanie B.M. Miller, Yunsun Nam et al. · Nature · 2008 · 139 citations · Full text

, , +7

The Plug Domain of the SecY Protein Stabilizes the Closed State of the Translocation Channel and Maintains a Membrane Seal

Weikai Li, Sol Schulman, Dana Boyd et al. · Molecular Cell · 2007 · 123 citations · Full text

, , +16

Determining the Conductance of the SecY Protein Translocation Channel for Small Molecules

Sapar M. Saparov, Karl J. Erlandson, Kurt S. Cannon et al. · Molecular Cell · 2007 · 112 citations · Full text

, , +11

SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies

Sabrina Lusvarghi, Simon Pollett, Sabari Nath Neerukonda et al. · Science Translational Medicine · 2022 · 95 citations · Full text

, , +17

1–5 of 18